DR. KATHERINE DUER LAGUARDIA, MD,MPH
Medical Practice at Gracie Sq, New York, NY
License number
New York 152053
Category
Medical Practice
Type
Obstetrics & Gynecology
License number
New York 152053
Category
Medical Practice
Type
Gynecology
License number
New York 152053
Category
Medical Practice
Type
Public Health & General Preventive Medicine
Address
Address
9 Gracie Sq SUITE 1FW, New York, NY 10028
Phone
(212) 570-1064
(212) 327-0518 (Fax)
(212) 327-0518 (Fax)
Personal information
See more information about KATHERINE DUER LAGUARDIA at radaris.comName
Address
Phone
9 Gracie Sq APT 5, New York, NY 10028
Professional information
Asst. Clin Prof Ob/Gyn At Mt Sinai School Of Medicine
Location:
Greater New York City Area
Industry:
Hospital & Health Care
Education:
Columbia University Mailman School of Public Health 1985 - 1987
MPH The George Washington University School of Medicine and Health Sciences 1978 - 1981
MD, MEDICINE
MPH The George Washington University School of Medicine and Health Sciences 1978 - 1981
MD, MEDICINE
Awards:
"Equality Award"
Order of the Sons of Italy in America, Loggia Uguaglianza No. 83
101st Anniversary Award acknolwedging special merit and grateful appreciation is conferred upon Dr. Katherine Duer LaGuardia by the Loggia Uguaglianza, est in 1911, in the Bronx. The award was presented on October 28, 2012 by the Consul General of Italy, Honorable Natalia Quintavale,Justice Dominic Massaro of the Supreme Court of the Bronx, and State President of the Grand Lodge of New York, Mr. Thom A Lupo, at the Italian Consulate in Manhattan. Dr. LaGuardia follows her grandfather, Mayor Fiorello H. LaGuardia, who received the award in 1935.
Order of the Sons of Italy in America, Loggia Uguaglianza No. 83
101st Anniversary Award acknolwedging special merit and grateful appreciation is conferred upon Dr. Katherine Duer LaGuardia by the Loggia Uguaglianza, est in 1911, in the Bronx. The award was presented on October 28, 2012 by the Consul General of Italy, Honorable Natalia Quintavale,Justice Dominic Massaro of the Supreme Court of the Bronx, and State President of the Grand Lodge of New York, Mr. Thom A Lupo, at the Italian Consulate in Manhattan. Dr. LaGuardia follows her grandfather, Mayor Fiorello H. LaGuardia, who received the award in 1935.
Dr. Katherine D Laguardia, New York NY - MD (Doctor of Medicine)
Specialties:
Obstetrics & Gynecology
Address:
9 Gracie Sq, New York 10028
(212) 570-1064 (Phone), (212) 327-0518 (Fax)
(212) 570-1064 (Phone), (212) 327-0518 (Fax)
Certifications:
Obstetrics & Gynecology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
George Washington University / School of Medicine And Health Sciences
Graduated: 1981
New York Presbyterian Hospital-New York Weill Cornell Center
George Washington University / School of Medicine And Health Sciences
Graduated: 1981
New York Presbyterian Hospital-New York Weill Cornell Center
Katherine Duer Laguardia, New York NY
Specialties:
OB-GYN
Address:
9 Gracie Sq, New York, NY 10028
Education:
Columbia University - Master of Public Health
George Washington University, Medical School - Doctor of Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Fellowship - Public Health
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Preventive Medicine (General, Public Health, Occ Med, Aer)
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Obstetrics and Gynecology
George Washington University, Medical School - Doctor of Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Fellowship - Public Health
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Preventive Medicine (General, Public Health, Occ Med, Aer)
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Obstetrics and Gynecology
Board certifications:
American Board of Obstetrics and Gynecology Certification in Obstetrics & Gynecology
Prinicpal At Gynopharma
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Extended Triphasic Contraceptive Regimens
US Patent:
2005009, Apr 28, 2005
Filed:
Sep 30, 2004
Appl. No.:
10/955276
Inventors:
Katherine LaGuardia - New York City NY, US
International Classification:
A61K031/56
US Classification:
514170000
Abstract:
An extended triphasic oral contraceptive regimen is disclosed. According to the disclosed regimen, a combination of an estrogen and a progestin is administered for at least 42 consecutive days followed by a hormone-free period of from 4 to 8 days. The estrogen and progestin are administered in a contraceptively effective daily dosage for a sequence of at least two cycles of at least 21 days, wherein the estrogen dosage remains constant over each cycle and the progestin dosage increases in three phases over each cycle.
Treatment Of Hot Flashes Using Muscarinic Receptor Antagonists
US Patent:
2007028, Dec 6, 2007
Filed:
May 31, 2007
Appl. No.:
11/755907
Inventors:
Katherine D. LaGuardia - New York NY, US
International Classification:
A61K 31/24
US Classification:
514540
Abstract:
The present invention relates to a method of treating hot flashes by administering a muscarinic receptor antagonist. The method is useful for treating peri- and post-menopausal women, including women who have undergone surgically induced menopause.
Extended Transdermal Contraceptive Regimens
US Patent:
2004014, Jul 22, 2004
Filed:
Jul 24, 2003
Appl. No.:
10/626434
Inventors:
Andrew Friedman - Princeton NJ, US
Katherine LaGuardia - New York NY, US
Katherine LaGuardia - New York NY, US
International Classification:
A61K031/56
US Classification:
514/170000, 424/449000
Abstract:
A method of contraception is described comprising the step of administering to a menstruating female a cycle of contraceptive therapy, said cycle of therapy including, for at least 42 successive days, the administration of a combination of an estrogen and a progestogen in a contraceptively effective daily dosage wherein said progestogen is a potent sulfatase inhibiting progestogen and said cycle of therapy including 4-8 days which are free of estrogen administration following said at least 42 successive days. A method of contraception is also described which provides enhanced bleeding control and enhanced continuation and satisfaction rates in menstruating females using the method.